Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib

Fig. 6

Correlation analysis between TMB and multiple variables. A Correlation analyses between TMB and multiple variables. B Comparison of TMB value between patients with longer PFS1 (≥ 12 months) and shorter PFS1 (< 12 months). C Comparison of the percentage of TMB-H between patients with longer PFS1 (≥ 12 months) and shorter PFS1 (< 12 months)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us